Back to search

University of Ioannina

Μελέτη της έκφρασης ισόμορφων φωσφολιπάσης Α2 σε ασθενείς με καρκίνο του παχέος εντέρου

Abstract

dc:description

Background/Aim: Phospholipases A2 (PLA2) are enzymes that regulate metabolism of the phospholipids by hydrolyzing them into fatty acids. Peroxiredoxin-6 (PRDX-6) is a protein acting as antioxidant enzyme and partially as PLA2 phospholipase involved in a variety of metabolic functions including mainly the intracellular hydrogen peroxide (H2O2) levels reduction and the repair of altered cellular membranes. They play a critical role in cellular signaling, inflammation, atherosclerosis and in cancer. The aim of this study is to investigate the expression of PLA2G2A, PLA2G3, PRDX6 in colon adenocarcinomas (CRC).Methods: Gene /protein tissue expression was studied at tissue and plasma levels by total protein assay Lowry method, protein electrophoresis in denatured polyacrylamide gel (SDS-PAGE), immunoblotting of proteins, total RNA content assay isolation and purity control, mRNA reverse transcription cDNA synthesis and quantitative real-time PCR (qRT-PCR) in 14 CRC patients with a mean age 73.5 (53-91). In addition, a series of thirty (n = 30) formalin-fixed, paraffin-embedded tissue sections of primary CRCs of patients with a mean age of 77 (53-90) were studied. Immunohistochemistry and digital image analysis (Digital Image Analysis) were performed.Results: Statistically significant plasma levels between CRC and healthy controls for PLA2G2A were found in 7/14 patients. A statistically significant correlation (PLA2G2A hyperconcentration) was observed at mRNA level between tumor and non-cancerous surrounding tissues. PLA2G2A protein over expression was observed in 23/30 (76.6%) cases, whereas 7/30 (23.4%) CRC tissues demonstrated low protein levels, respectively. PLA2G2A overall expression was strongly associated with tumor diameter (p=0.004), whereas other statistical significances were not assessed (stage: p=0.971, inflammatory infiltration: p=0.795; carcinoma location: p=0.340; differentiation grade: p=0.748; gender: p=0.369; ulceration: p=0.433). Statistically significant plasma levels between CRC and healthy controls for PLA2G3 were found in 12/14 patients. A statistically significant correlation (PLA2G3 hyperconcentration) was not observed at mRNA level between tumor and non-cancerous surrounding tissues. PLA2G3 protein over expression (increased immunostaining levels) was observed in 23/30 (76.6%) cases, whereas 07/30 (23.40%) CRCs tissues demonstrated low protein levels, respectively. PLA2G3 overall expression was strongly associated with the grade and tumor localization of the examined tumors (p=0.001, p=0.027, respectively), whereas other statistical significances were not assessed (inflammatory infiltration: p=0.846; stage: p=0.755; tumor diameter: p=0.300; ulceration: p=0.872; gender: p=0.902). No statistically significant plasma levels (however high in all 14 patients) between CRC and healthy controls for PRDX6 were found in 12/14 patients. High plasma levels of PRDX6-aiPLA2 were found in all CRC patients compared to healthy controls without however statistical significance. A statistically significant correlation (hypoconcentration) was observed at mRNA level between tumor and non-cancerous surrounding tissues (mRNA-PRDX6 levels reduced). PRDX-6 protein over expression was observed in 12/30 (40%) cases, whereas 18/30 (60%) CRC tissues demonstrated low to moderate protein levels, respectively. PRDX-6 overall expression was strongly associated with the stage of the examined tumors (p=0.011), whereas other statistical significances were not assessed (inflammatory infiltration: p=0.364; carcinoma location: p=0.93; differentiation grade: p=0.517; tumor diameter: p=0.983; ulceration: p=0.622). Conclusions: Elevated serum and mRNA levels and overexpression of PLA2G2A observed in a significant subset of CRC associated with advanced tumor growth (increased diameter) make it an interesting biomarker and potential therapeutic target in CRC. Elevated serum levels, non-statistical significance of mRNA and overexpression of PLA2G3 observed in a significant CRC subset in immunohistochemistry associated with aggressive biological behavior (tumor differentiation) and a kind of selectivity in localization of malignant substrate allow a broader research. The elevated serum concentration in both healthy controls and patients, the higher mRNA concentration in non-cancerous surrounding tissues of the tumor and the overexpression of PRDX-6 observed in a significant subset of CRC related to aggressive biological behavior (advanced stage) provide material for a more extensive research of the enzyme regarding redox effects in the primary CRC or during chemotherapy.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Falidas, Evangelos
  • Φαλίδας, Ευάγγελος

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/51668

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Falidas, Evangelos; Φαλίδας, Ευάγγελος. Μελέτη της έκφρασης ισόμορφων φωσφολιπάσης Α2 σε ασθενείς με καρκίνο του παχέος εντέρου. University of Ioannina, 2022. http://hdl.handle.net/10442/hedi/51668